胆管がんの世界市場レポート 2025年

胆管がん市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR8.7％で36億3,000万米ドルに成長します。予測期間の成長は、胆管がんの罹患率の増加、胆管がんおよび肝がんの症例数の増加、胆道がん（BTC）の有病率の増加、研究開発活動の活発化、高度な治療オプションに対する需要の高まりによってもたらされる可能性があります。主な動向としては、診断技術の進歩、医療技術の革新、内視鏡画像の改善、継続的な技術革新、個別化医療アプローチの拡大などが挙げられます。

肝疾患の有病率の増加は、胆管がん市場の成長を促進すると予想されます。肝疾患には、肝炎、肝硬変、脂肪性肝疾患、肝がんなど、肝機能を損なう幅広い疾患が含まれます。肝臓疾患の罹患率の増加は、過度のアルコール摂取、不健康な食生活、肥満、ウイルス感染（B型肝炎やC型肝炎など）、座りがちなライフスタイルなどの要因に起因しています。胆管の閉塞や機能不全は、黄疸や胆汁うっ滞などの重篤な肝臓関連合併症を引き起こすことが多いため、胆管がんは肝臓病を理解する上で重要な役割を果たします。例えば、英国の政府機関であるThe House of Commons Libraryによると、2024年4月、英国では2022年に75歳未満の1万593人が肝臓病で死亡し、死亡率の上昇傾向が続いています。その割合は2021年の人口10万人当たり21.2人から2022年には21.4人に増加しました。その結果、肝疾患の有病率の増加が胆管がん市場の拡大に拍車をかけています。

胆管がん市場の主要企業は、治療成果を高め、副作用を最小限に抑え、この稀で複雑ながんに直面する患者に新たな希望を提供するため、革新的な標的療法に投資しています。標的療法は、がんの増殖を促進する特定の遺伝子、タンパク質、または分子メカニズムに焦点を当て、全身毒性を抑えながら腫瘍の進行を抑制することを目的としています。例えば、2023年8月、日本の製薬会社である大鵬薬品工業株式会社は、大鵬薬品工業株式会社を買収しました。日本の製薬会社である大鵬薬品工業株式会社は、FGFR阻害剤「LYTGOBI錠4mg」を発売しました。この経口製剤は、簡便な治療選択肢を提供し、患者のコンプライアンスと投与の簡便性を向上させる。LYTGOBIは、FGFR2融合変異または再配列変異を有する進行性または転移性の胆管がん患者を対象として設計されており、がん治療における重要なアンメットニーズに対応しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- マクロ経済シナリオ金利、インフレ、地政学、新型コロナウイルス感染症の影響と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界胆管がんPESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の胆管がん市場：成長率分析
• 世界の胆管がん市場の実績：規模と成長, 2019-2024
• 世界の胆管がん市場の予測：規模と成長, 2024-2029, 2034F
• 世界胆管がん総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の胆管がん市場：タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 肝外胆管がん（eCCA）
• 肝内胆管がん（iCCA）
• 世界の胆管がん市場治療の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 手術
• 化学療法
• 放射線治療
• 標的療法
• 免疫療法
• 世界の胆管がん市場病気の段階別、実績と予測, 2019-2024, 2024-2029F, 2034F
• ローカライズ
• 地域
• 遠い
• 世界の胆管がん市場診断タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 画像検査
• 生検
• 血液検査
• 世界の胆管がん市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• クリニック
• 外来手術センター
• がん調査機関
• 世界の胆管がん市場、肝外胆管がん（eCCA）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 門脈周囲胆管がん（クラトスキン腫瘍）
• 遠位胆管がん
• 世界の胆管がん市場、肝内胆管がん（iCCA）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 塊形成iCCA
• 乳管周囲浸潤性iCCA
• 乳管内成長iCCA

第7章 地域別・国別分析

• 世界の胆管がん市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の胆管がん市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 胆管がん市場：競合情勢
• 胆管がん市場：企業プロファイル
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Amgen Inc.
• Merck & Co. Inc.
• Boehringer Ingelheim International GmbH
• Eisai Co. Ltd.
• Genentech Inc.
• Jazz Pharmaceuticals plc
• Incyte Corporation
• Exelixis Inc.
• Hutchison China MediTech Limited
• Zymeworks Inc.
• Mirati Therapeutics Inc.
• RenovoRx Inc.
• Spectrum Pharmaceuticals Inc.
• Specialised Therapeutics Pty Ltd
• Taiho Pharmaceutical Co. Ltd.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 胆管がん市場2029：新たな機会を提供する国
• 胆管がん市場2029：新たな機会を提供するセグメント
• 胆管がん市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Bile duct cancer is a rare malignancy that develops in the bile ducts, which transport bile from the liver to the gallbladder and small intestine. It is often diagnosed in advanced stages and can cause symptoms such as jaundice, weight loss, and abdominal pain.

The primary types of bile duct cancer include extrahepatic bile duct cancer (ECC) and intrahepatic bile duct cancer (ICC). ECC occurs in the bile ducts outside the liver, typically where they exit the liver and connect to the small intestine. Treatment options for ECC include surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. It is categorized by stage into localized, regional, and distant forms, with diagnosis typically involving imaging tests, biopsy, and blood tests. These diagnostic and treatment approaches are utilized by various end users, including hospitals, clinics, ambulatory surgical centers, and cancer research institutes.

The bile duct cancer market research report is one of a series of new reports from The Business Research Company that provides bile duct cancer market statistics, including the bile duct cancer industry global market size, regional shares, competitors with the bile duct cancer market share, detailed bile duct cancer market segments, market trends, and opportunities, and any further data you may need to thrive in the bile duct cancer industry. This bile duct cancer market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The bile duct cancer market size has grown strongly in recent years. It will grow from $2.39 billion in 2024 to $2.60 billion in 2025 at a compound annual growth rate (CAGR) of 9.1%. The growth during the historic period can be attributed to greater exposure to toxic chemicals, increased awareness of bile duct cancer, a growing geriatric population, a rising incidence of bile duct and pancreatic cancers, and higher investments in healthcare infrastructure.

The bile duct cancer market size is expected to see strong growth in the next few years. It will grow to $3.63 billion in 2029 at a compound annual growth rate (CAGR) of 8.7%. The growth in the forecast period can be driven by the increasing incidence of bile duct cancer, a rising number of cases of bile duct and liver cancer, a growing prevalence of biliary tract cancers (BTCs), an uptick in research and development activities, and a higher demand for advanced treatment options. Key trends include advancements in diagnostic techniques, innovations in medical technology, improvements in endoscopic imaging, ongoing technological innovations, and the expansion of personalized medicine approaches.

The increasing prevalence of liver diseases is anticipated to drive the growth of the bile duct cancer market. Liver diseases encompass a broad range of conditions that impair liver function, including hepatitis, cirrhosis, fatty liver disease, and liver cancer. The rising incidence of liver diseases is attributed to factors such as excessive alcohol consumption, unhealthy diets, obesity, viral infections (such as hepatitis B and C), and sedentary lifestyles. Bile duct cancer plays a crucial role in understanding liver diseases, as bile duct obstruction or dysfunction often leads to severe liver-related complications, including jaundice and cholestasis. For instance, in April 2024, according to The House of Commons Library, a UK-based government department, 10,593 individuals under the age of 75 in England died from liver disease in 2022, continuing the upward trend in mortality rates. The rate increased from 21.2 per 100,000 population in 2021 to 21.4 per 100,000 in 2022. Consequently, the growing prevalence of liver diseases is fueling the expansion of the bile duct cancer market.

Leading companies in the bile duct cancer market are investing in innovative targeted therapies to enhance treatment outcomes, minimize side effects, and offer new hope to patients facing this rare and complex cancer. Targeted therapies focus on specific genes, proteins, or molecular mechanisms that drive cancer growth, aiming to inhibit tumor progression while reducing systemic toxicity. For example, in August 2023, Taiho Pharmaceutical Co. Ltd., a Japan-based pharmaceutical company, introduced FGFR Inhibitor LYTGOBI Tablets 4mg. This oral formulation provides a convenient treatment option, improving patient compliance and ease of administration. LYTGOBI is designed for patients with advanced or metastatic bile duct cancer harboring FGFR2 fusion or rearrangement mutations, addressing a significant unmet need in cancer care.

In July 2023, Lucence, a US-based precision health company, partnered with Innovent Biologics Inc. to enhance molecular diagnostics for bile duct cancer in Hong Kong. Through this collaboration, Lucence aims to integrate Innovent Biologics' advanced targeted therapies into its diagnostic services, improving early detection and personalized treatment approaches for patients. Innovent Biologics Inc. is a China-based biotechnology company specializing in the development, manufacturing, and commercialization of innovative biopharmaceuticals.

Major players in the bile duct cancer market are AbbVie Inc., Bristol-Myers Squibb Company, AstraZeneca plc, Eli Lilly and Company, Gilead Sciences Inc., Amgen Inc., Merck & Co. Inc., Boehringer Ingelheim International GmbH, Eisai Co. Ltd., Genentech Inc., Jazz Pharmaceuticals plc, Incyte Corporation, Exelixis Inc., Hutchison China MediTech Limited, Zymeworks Inc., Mirati Therapeutics Inc., RenovoRx Inc., Spectrum Pharmaceuticals Inc., Specialised Therapeutics Pty Ltd, Taiho Pharmaceutical Co. Ltd.

North America was the largest region in the bile duct cancer market in 2024. The regions covered in bile duct cancer report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the bile duct cancer market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bile duct cancer market includes revenues earned by entities by services such as diagnostic services, treatment services, clinical trials, and research services, and related products such as pharmaceutical products, diagnostic products, and supportive care products. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bile Duct Cancer Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bile duct cancer market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bile duct cancer ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bile duct cancer market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Extrahepatic Bile Duct Cancer (eCCA); Intrahepatic Bile Duct Cancer (iCCA)
• 2) By Treatment Type: Surgery; Chemotherapy; Radiation Therapy; Targeted Therapy; Immunotherapy
• 3) By Stage of Disease: Localized; Regional; Distant
• 4) By Diagnosis Type: Imaging Tests; Biopsy; Blood Tests
• 5) By End User: Hospitals; Clinics; Ambulatory Surgical Centers; Cancer Research Institutes
• Subsegments:
• 1) By Extrahepatic Bile Duct Cancer (eCCA): Perihilar Cholangiocarcinoma (Klatskin Tumor); Distal Cholangiocarcinoma
• 2) By Intrahepatic Bile Duct Cancer (iCCA): Mass-Forming iCCA; Periductal Infiltrating iCCA; Intraductal Growth iCCA
• Companies Mentioned: AbbVie Inc.; Bristol-Myers Squibb Company; AstraZeneca plc; Eli Lilly and Company; Gilead Sciences Inc.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bile Duct Cancer Market Characteristics

3. Bile Duct Cancer Market Trends And Strategies

4. Bile Duct Cancer Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bile Duct Cancer Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bile Duct Cancer PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bile Duct Cancer Market Growth Rate Analysis
• 5.4. Global Bile Duct Cancer Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bile Duct Cancer Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bile Duct Cancer Total Addressable Market (TAM)

6. Bile Duct Cancer Market Segmentation

• 6.1. Global Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Extrahepatic Bile Duct Cancer (eCCA)
• Intrahepatic Bile Duct Cancer (iCCA)
• 6.2. Global Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgery
• Chemotherapy
• Radiation Therapy
• Targeted Therapy
• Immunotherapy
• 6.3. Global Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Localized
• Regional
• Distant
• 6.4. Global Bile Duct Cancer Market, Segmentation By Diagnosis Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Tests
• Biopsy
• Blood Tests
• 6.5. Global Bile Duct Cancer Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinics
• Ambulatory Surgical Centers
• Cancer Research Institutes
• 6.6. Global Bile Duct Cancer Market, Sub-Segmentation Of Extrahepatic Bile Duct Cancer (eCCA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Perihilar Cholangiocarcinoma (Klatskin Tumor)
• Distal Cholangiocarcinoma
• 6.7. Global Bile Duct Cancer Market, Sub-Segmentation Of Intrahepatic Bile Duct Cancer (iCCA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mass-Forming iCCA
• Periductal Infiltrating iCCA
• Intraductal Growth iCCA

7. Bile Duct Cancer Market Regional And Country Analysis

• 7.1. Global Bile Duct Cancer Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bile Duct Cancer Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bile Duct Cancer Market

• 8.1. Asia-Pacific Bile Duct Cancer Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bile Duct Cancer Market

• 9.1. China Bile Duct Cancer Market Overview
• 9.2. China Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bile Duct Cancer Market

• 10.1. India Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bile Duct Cancer Market

• 11.1. Japan Bile Duct Cancer Market Overview
• 11.2. Japan Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bile Duct Cancer Market

• 12.1. Australia Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bile Duct Cancer Market

• 13.1. Indonesia Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bile Duct Cancer Market

• 14.1. South Korea Bile Duct Cancer Market Overview
• 14.2. South Korea Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bile Duct Cancer Market

• 15.1. Western Europe Bile Duct Cancer Market Overview
• 15.2. Western Europe Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bile Duct Cancer Market

• 16.1. UK Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bile Duct Cancer Market

• 17.1. Germany Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bile Duct Cancer Market

• 18.1. France Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bile Duct Cancer Market

• 19.1. Italy Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bile Duct Cancer Market

• 20.1. Spain Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bile Duct Cancer Market

• 21.1. Eastern Europe Bile Duct Cancer Market Overview
• 21.2. Eastern Europe Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bile Duct Cancer Market

• 22.1. Russia Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bile Duct Cancer Market

• 23.1. North America Bile Duct Cancer Market Overview
• 23.2. North America Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bile Duct Cancer Market

• 24.1. USA Bile Duct Cancer Market Overview
• 24.2. USA Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bile Duct Cancer Market

• 25.1. Canada Bile Duct Cancer Market Overview
• 25.2. Canada Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bile Duct Cancer Market

• 26.1. South America Bile Duct Cancer Market Overview
• 26.2. South America Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bile Duct Cancer Market

• 27.1. Brazil Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bile Duct Cancer Market

• 28.1. Middle East Bile Duct Cancer Market Overview
• 28.2. Middle East Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bile Duct Cancer Market

• 29.1. Africa Bile Duct Cancer Market Overview
• 29.2. Africa Bile Duct Cancer Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bile Duct Cancer Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bile Duct Cancer Market, Segmentation By Stage of Disease, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bile Duct Cancer Market Competitive Landscape And Company Profiles

• 30.1. Bile Duct Cancer Market Competitive Landscape
• 30.2. Bile Duct Cancer Market Company Profiles
  • 30.2.1. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Bristol-Myers Squibb Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Bile Duct Cancer Market Other Major And Innovative Companies

• 31.1. Amgen Inc.
• 31.2. Merck & Co. Inc.
• 31.3. Boehringer Ingelheim International GmbH
• 31.4. Eisai Co. Ltd.
• 31.5. Genentech Inc.
• 31.6. Jazz Pharmaceuticals plc
• 31.7. Incyte Corporation
• 31.8. Exelixis Inc.
• 31.9. Hutchison China MediTech Limited
• 31.10. Zymeworks Inc.
• 31.11. Mirati Therapeutics Inc.
• 31.12. RenovoRx Inc.
• 31.13. Spectrum Pharmaceuticals Inc.
• 31.14. Specialised Therapeutics Pty Ltd
• 31.15. Taiho Pharmaceutical Co. Ltd.

32. Global Bile Duct Cancer Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bile Duct Cancer Market

34. Recent Developments In The Bile Duct Cancer Market

35. Bile Duct Cancer Market High Potential Countries, Segments and Strategies

• 35.1 Bile Duct Cancer Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bile Duct Cancer Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bile Duct Cancer Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer